← Back to headlines
Dexcom raises 2026 revenue outlook, targets G7 conversion
Dexcom has increased its 2026 revenue outlook to $5.18B-$5.25B, aiming for nearly 50% U.S. G7 15 Day conversion by the end of the year.
31 Jul, 02:04 — 31 Jul, 02:04
Sources
Showing 1 of 1 sources


